Increased Reach & Awareness = Faster Enrollment

The biggest barrier to enrollment isn’t eligibility, it’s access. 

Most clinical trials don’t struggle because patients don’t exist- they struggle because patients can’t easily participate. Traditional site models often require patients to travel significant distances, reducing access and constraining enrollment from the start. 

Community-based clinical trials change that dynamic by expanding where trials take place. Instead of asking patients to come to the trial, CBCTs bring the trial into the community- through local healthcare settings, mobile units, and trusted care environments. This expansion doesn’t just impact enrollment; it sets the foundation for retention and data quality. 

But access alone isn’t enough- access improves reach, but trust is what drives participation. 

CBCT site teams operate directly within local communities. They build relationships with local physicians and are rooted in the communities that they serve. When patients recognize the people delivering the trial and trust the setting, it reduces hesitation and increases participation. 

The result? Broader reach and faster enrollment. 

Still, enrollment is only the first milestone. Expanding access brings more patients into trials, but what happens next determines overall success- that’s where the Triple Effect truly takes shape. 

👉 See how expanded access drives the full Triple Effect: The Triple Effect of Community-Based Clinical Trials - EmVenio